O. Ilhan Et Al. , "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib," BONE MARROW TRANSPLANTATION , vol.55, pp.329-330, 2020
Ilhan, O. Et Al. 2020. A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib. BONE MARROW TRANSPLANTATION , vol.55 , 329-330.
Ilhan, O., Seval, G. C., Bozdag, S. C., Deveci, B., Pehlivan, M., KAYNAR, L., ... Yavasoglu, I.(2020). A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib. BONE MARROW TRANSPLANTATION , vol.55, 329-330.
Ilhan, Osman Et Al. "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib," BONE MARROW TRANSPLANTATION , vol.55, 329-330, 2020
Ilhan, Osman Et Al. "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib." BONE MARROW TRANSPLANTATION , vol.55, pp.329-330, 2020
Ilhan, O. Et Al. (2020) . "A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib." BONE MARROW TRANSPLANTATION , vol.55, pp.329-330.
@article{article, author={Osman Ilhan Et Al. }, title={A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib}, journal={BONE MARROW TRANSPLANTATION}, year=2020, pages={329-330} }